News

SARS-CoV-2 infection causes severe inflammation of the lungs and other vital organs. Why some infected individuals respond with an exaggerated immune response to the virus remains not well understood

There is still an urgent need for drugs against the new coronavirus. This urgency increases further with the emergence of new virus mutations that could push vaccines to their limits. For more than a

What started as the preliminary analysis of routine laboratory data has since evolved into the largest-ever study of viral load levels in patients with SARS-CoV-2. A team of researchers from the

An international research team, led by scientists from Tübingen and the German Center for Infection Research (DZIF) discovers additional component in staphylococcal cell wall that turns the bacterium

At the University Hospital of Tübingen, a clinical trial led by Prof. Dr. Peter Kremsner, Director of the Institute of Tropical Medicine, Travel Medicine and Human Parasitology and Dr. Rolf Fendel

In addition to the SARS coronavirus-2 that is currently prevalent worldwide, scientists continue to keep an eye on the related MERS coronavirus, as it, too, could potentially become a supra-regional

The successful treatment of multidrug-resistant tuberculosis requires clarification in advance as to which antibiotics the pathogens are resistant to. Classic testing in the laboratory is very time

DZIF scientists Prof. Rolf Hilgenfeld of the University of Lübeck and Dr. Albrecht von Brunn of the Ludwig-Maximilians University of Munich  discovered how SARS viruses enhance the production of viral

What exactly happens when the corona virus SARS-CoV-2 infects a cell? In an article published in Nature, a team from the Technical University of Munich (TUM) and the Max Planck Institute of

Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses. Will the same apply to COVID-19 vaccines? In order to gauge whether and to what extent